Medirom Healthcare Technologies (MRM) Gains from Investment Securities (2019 - 2023)

Medirom Healthcare Technologies has reported Gains from Investment Securities for 5 years, with the latest figure at $47.02 in Q4 2023.

• For the quarter ending Q4 2023, Gains from Investment Securities fell 98.88% year-over-year to $47.02; the trailing twelve-month figure through Dec 2023 stood at $47.02 (down 98.88% YoY), and the FY2024 full-year result was $349582.4, up 13.03% from the prior year.
• Gains from Investment Securities for Q4 2023 stood at $47.02, down from $4199.2 in the prior quarter.
• The five-year high for Gains from Investment Securities was $5276.6 in Q4 2021, with the low at $47.02 in Q4 2023.
• Average Gains from Investment Securities over 5 years is $3415.7, with a median of $4199.2 recorded in 2022.
• Year-over-year, Gains from Investment Securities soared 90.13% in 2021 and plunged 98.88% in 2023.
• Tracing MRM's Gains from Investment Securities over 5 years: stood at $4780.1 in 2019, then sank by 41.94% to $2775.3 in 2020, then soared by 90.13% to $5276.6 in 2021, then retreated by 20.42% to $4199.2 in 2022, then sank by 98.88% to $47.02 in 2023.
• The last three Gains from Investment Securities figures came in at $47.02 (Q4 2023), $4199.2 (Q4 2022), and $5276.6 (Q4 2021), per Business Quant data.

Peer Comparison